0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Phenylpropanolamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-15L8332
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Phenylpropanolamine Market Insights Forecast to 2028
BUY CHAPTERS

Phenylpropanolamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15L8332
Report
November 2024
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phenylpropanolamine - Market Size

The global market for Phenylpropanolamine was estimated to be worth US$ 1569 million in 2023 and is forecast to a readjusted size of US$ 2185.2 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Phenylpropanolamine - Market

Phenylpropanolamine - Market

Phenylpropanolamine (PPA) is a sympathomimetic agent which is used as a decongestant and appetite suppressant. It was commonly used in prescription and over-the-counter cough and cold preparations. In veterinary medicine, it is used to control urinary incontinence in dogs
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Phenylpropanolamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phenylpropanolamine by region & country, by Type, and by Application.
The Phenylpropanolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylpropanolamine.
Market Segmentation

Scope of Phenylpropanolamine - Market Report

Report Metric Details
Report Name Phenylpropanolamine - Market
Forecasted market size in 2030 US$ 2185.2 million
CAGR 4.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Tablet
  • Capsule
  • Syrup
Segment by Application
  • Human
  • Veterinary
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Riemser Pharma, Abbott, Gräub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Phenylpropanolamine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Phenylpropanolamine - Market size in 2030?

Ans: The Phenylpropanolamine - Market size in 2030 will be US$ 2185.2 million.

Who are the main players in the Phenylpropanolamine - Market report?

Ans: The main players in the Phenylpropanolamine - Market are Riemser Pharma, Abbott, Gräub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo

What are the Application segmentation covered in the Phenylpropanolamine - Market report?

Ans: The Applications covered in the Phenylpropanolamine - Market report are Human, Veterinary

What are the Type segmentation covered in the Phenylpropanolamine - Market report?

Ans: The Types covered in the Phenylpropanolamine - Market report are Tablet, Capsule, Syrup

1 Market Overview
1.1 Phenylpropanolamine Product Introduction
1.2 Global Phenylpropanolamine Market Size Forecast
1.2.1 Global Phenylpropanolamine Sales Value (2019-2030)
1.2.2 Global Phenylpropanolamine Sales Volume (2019-2030)
1.2.3 Global Phenylpropanolamine Sales Price (2019-2030)
1.3 Phenylpropanolamine Market Trends & Drivers
1.3.1 Phenylpropanolamine Industry Trends
1.3.2 Phenylpropanolamine Market Drivers & Opportunity
1.3.3 Phenylpropanolamine Market Challenges
1.3.4 Phenylpropanolamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Phenylpropanolamine Players Revenue Ranking (2023)
2.2 Global Phenylpropanolamine Revenue by Company (2019-2024)
2.3 Global Phenylpropanolamine Players Sales Volume Ranking (2023)
2.4 Global Phenylpropanolamine Sales Volume by Company Players (2019-2024)
2.5 Global Phenylpropanolamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Phenylpropanolamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Phenylpropanolamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Phenylpropanolamine
2.9 Phenylpropanolamine Market Competitive Analysis
2.9.1 Phenylpropanolamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Phenylpropanolamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylpropanolamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsule
3.1.3 Syrup
3.2 Global Phenylpropanolamine Sales Value by Type
3.2.1 Global Phenylpropanolamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Phenylpropanolamine Sales Value, by Type (2019-2030)
3.2.3 Global Phenylpropanolamine Sales Value, by Type (%) (2019-2030)
3.3 Global Phenylpropanolamine Sales Volume by Type
3.3.1 Global Phenylpropanolamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Phenylpropanolamine Sales Volume, by Type (2019-2030)
3.3.3 Global Phenylpropanolamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Phenylpropanolamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Veterinary
4.2 Global Phenylpropanolamine Sales Value by Application
4.2.1 Global Phenylpropanolamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Phenylpropanolamine Sales Value, by Application (2019-2030)
4.2.3 Global Phenylpropanolamine Sales Value, by Application (%) (2019-2030)
4.3 Global Phenylpropanolamine Sales Volume by Application
4.3.1 Global Phenylpropanolamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Phenylpropanolamine Sales Volume, by Application (2019-2030)
4.3.3 Global Phenylpropanolamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Phenylpropanolamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Phenylpropanolamine Sales Value by Region
5.1.1 Global Phenylpropanolamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Phenylpropanolamine Sales Value by Region (2019-2024)
5.1.3 Global Phenylpropanolamine Sales Value by Region (2025-2030)
5.1.4 Global Phenylpropanolamine Sales Value by Region (%), (2019-2030)
5.2 Global Phenylpropanolamine Sales Volume by Region
5.2.1 Global Phenylpropanolamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Phenylpropanolamine Sales Volume by Region (2019-2024)
5.2.3 Global Phenylpropanolamine Sales Volume by Region (2025-2030)
5.2.4 Global Phenylpropanolamine Sales Volume by Region (%), (2019-2030)
5.3 Global Phenylpropanolamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Phenylpropanolamine Sales Value, 2019-2030
5.4.2 North America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Phenylpropanolamine Sales Value, 2019-2030
5.5.2 Europe Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Phenylpropanolamine Sales Value, 2019-2030
5.6.2 Asia Pacific Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Phenylpropanolamine Sales Value, 2019-2030
5.7.2 South America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Phenylpropanolamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Phenylpropanolamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Phenylpropanolamine Sales Value
6.2.1 Key Countries/Regions Phenylpropanolamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Phenylpropanolamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Phenylpropanolamine Sales Value, 2019-2030
6.3.2 United States Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Phenylpropanolamine Sales Value, 2019-2030
6.4.2 Europe Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Phenylpropanolamine Sales Value, 2019-2030
6.5.2 China Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Phenylpropanolamine Sales Value, 2019-2030
6.6.2 Japan Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Phenylpropanolamine Sales Value, 2019-2030
6.7.2 South Korea Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Phenylpropanolamine Sales Value, 2019-2030
6.8.2 Southeast Asia Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Phenylpropanolamine Sales Value, 2019-2030
6.9.2 India Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Phenylpropanolamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Riemser Pharma
7.1.1 Riemser Pharma Company Information
7.1.2 Riemser Pharma Introduction and Business Overview
7.1.3 Riemser Pharma Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Riemser Pharma Phenylpropanolamine Product Offerings
7.1.5 Riemser Pharma Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Phenylpropanolamine Product Offerings
7.2.5 Abbott Recent Development
7.3 Gräub
7.3.1 Gräub Company Information
7.3.2 Gräub Introduction and Business Overview
7.3.3 Gräub Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Gräub Phenylpropanolamine Product Offerings
7.3.5 Gräub Recent Development
7.4 Helicon
7.4.1 Helicon Company Information
7.4.2 Helicon Introduction and Business Overview
7.4.3 Helicon Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Helicon Phenylpropanolamine Product Offerings
7.4.5 Helicon Recent Development
7.5 Eipico
7.5.1 Eipico Company Information
7.5.2 Eipico Introduction and Business Overview
7.5.3 Eipico Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Eipico Phenylpropanolamine Product Offerings
7.5.5 Eipico Recent Development
7.6 Schazoo
7.6.1 Schazoo Company Information
7.6.2 Schazoo Introduction and Business Overview
7.6.3 Schazoo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Schazoo Phenylpropanolamine Product Offerings
7.6.5 Schazoo Recent Development
7.7 GlaxoSmithKline (GSK)
7.7.1 GlaxoSmithKline (GSK) Company Information
7.7.2 GlaxoSmithKline (GSK) Introduction and Business Overview
7.7.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Offerings
7.7.5 GlaxoSmithKline (GSK) Recent Development
7.8 Roemmers
7.8.1 Roemmers Company Information
7.8.2 Roemmers Introduction and Business Overview
7.8.3 Roemmers Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Roemmers Phenylpropanolamine Product Offerings
7.8.5 Roemmers Recent Development
7.9 Armoxindo
7.9.1 Armoxindo Company Information
7.9.2 Armoxindo Introduction and Business Overview
7.9.3 Armoxindo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Armoxindo Phenylpropanolamine Product Offerings
7.9.5 Armoxindo Recent Development
7.10 Asuncion
7.10.1 Asuncion Company Information
7.10.2 Asuncion Introduction and Business Overview
7.10.3 Asuncion Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Asuncion Phenylpropanolamine Product Offerings
7.10.5 Asuncion Recent Development
7.11 Medlink
7.11.1 Medlink Company Information
7.11.2 Medlink Introduction and Business Overview
7.11.3 Medlink Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Medlink Phenylpropanolamine Product Offerings
7.11.5 Medlink Recent Development
7.12 Sanofi-Aventis
7.12.1 Sanofi-Aventis Company Information
7.12.2 Sanofi-Aventis Introduction and Business Overview
7.12.3 Sanofi-Aventis Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sanofi-Aventis Phenylpropanolamine Product Offerings
7.12.5 Sanofi-Aventis Recent Development
7.13 Tempo Scan Pacific
7.13.1 Tempo Scan Pacific Company Information
7.13.2 Tempo Scan Pacific Introduction and Business Overview
7.13.3 Tempo Scan Pacific Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Tempo Scan Pacific Phenylpropanolamine Product Offerings
7.13.5 Tempo Scan Pacific Recent Development
7.14 Carinopharm
7.14.1 Carinopharm Company Information
7.14.2 Carinopharm Introduction and Business Overview
7.14.3 Carinopharm Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Carinopharm Phenylpropanolamine Product Offerings
7.14.5 Carinopharm Recent Development
7.15 Meda
7.15.1 Meda Company Information
7.15.2 Meda Introduction and Business Overview
7.15.3 Meda Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Meda Phenylpropanolamine Product Offerings
7.15.5 Meda Recent Development
7.16 IBL Healthcare
7.16.1 IBL Healthcare Company Information
7.16.2 IBL Healthcare Introduction and Business Overview
7.16.3 IBL Healthcare Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 IBL Healthcare Phenylpropanolamine Product Offerings
7.16.5 IBL Healthcare Recent Development
7.17 Gracia Pharmindo
7.17.1 Gracia Pharmindo Company Information
7.17.2 Gracia Pharmindo Introduction and Business Overview
7.17.3 Gracia Pharmindo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Gracia Pharmindo Phenylpropanolamine Product Offerings
7.17.5 Gracia Pharmindo Recent Development
8 Industry Chain Analysis
8.1 Phenylpropanolamine Industrial Chain
8.2 Phenylpropanolamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Phenylpropanolamine Sales Model
8.5.2 Sales Channel
8.5.3 Phenylpropanolamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Phenylpropanolamine Market Trends
    Table 2. Phenylpropanolamine Market Drivers & Opportunity
    Table 3. Phenylpropanolamine Market Challenges
    Table 4. Phenylpropanolamine Market Restraints
    Table 5. Global Phenylpropanolamine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Phenylpropanolamine Revenue Market Share by Company (2019-2024)
    Table 7. Global Phenylpropanolamine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Phenylpropanolamine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Phenylpropanolamine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Phenylpropanolamine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Phenylpropanolamine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Phenylpropanolamine
    Table 13. Global Phenylpropanolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylpropanolamine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Phenylpropanolamine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Phenylpropanolamine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Phenylpropanolamine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Phenylpropanolamine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Phenylpropanolamine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Phenylpropanolamine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Phenylpropanolamine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Phenylpropanolamine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Phenylpropanolamine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Phenylpropanolamine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Phenylpropanolamine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Phenylpropanolamine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Phenylpropanolamine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Phenylpropanolamine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Phenylpropanolamine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Phenylpropanolamine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Phenylpropanolamine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Phenylpropanolamine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Phenylpropanolamine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Phenylpropanolamine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Phenylpropanolamine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Phenylpropanolamine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Phenylpropanolamine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Phenylpropanolamine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Phenylpropanolamine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Phenylpropanolamine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Phenylpropanolamine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Phenylpropanolamine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Phenylpropanolamine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Phenylpropanolamine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Phenylpropanolamine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Phenylpropanolamine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Phenylpropanolamine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Phenylpropanolamine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Phenylpropanolamine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Phenylpropanolamine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Phenylpropanolamine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Phenylpropanolamine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Phenylpropanolamine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Phenylpropanolamine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Phenylpropanolamine Sales Volume, (2025-2030) & (K Units)
    Table 57. Riemser Pharma Company Information
    Table 58. Riemser Pharma Introduction and Business Overview
    Table 59. Riemser Pharma Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Riemser Pharma Phenylpropanolamine Product Offerings
    Table 61. Riemser Pharma Recent Development
    Table 62. Abbott Company Information
    Table 63. Abbott Introduction and Business Overview
    Table 64. Abbott Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Abbott Phenylpropanolamine Product Offerings
    Table 66. Abbott Recent Development
    Table 67. Gräub Company Information
    Table 68. Gräub Introduction and Business Overview
    Table 69. Gräub Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Gräub Phenylpropanolamine Product Offerings
    Table 71. Gräub Recent Development
    Table 72. Helicon Company Information
    Table 73. Helicon Introduction and Business Overview
    Table 74. Helicon Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Helicon Phenylpropanolamine Product Offerings
    Table 76. Helicon Recent Development
    Table 77. Eipico Company Information
    Table 78. Eipico Introduction and Business Overview
    Table 79. Eipico Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Eipico Phenylpropanolamine Product Offerings
    Table 81. Eipico Recent Development
    Table 82. Schazoo Company Information
    Table 83. Schazoo Introduction and Business Overview
    Table 84. Schazoo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Schazoo Phenylpropanolamine Product Offerings
    Table 86. Schazoo Recent Development
    Table 87. GlaxoSmithKline (GSK) Company Information
    Table 88. GlaxoSmithKline (GSK) Introduction and Business Overview
    Table 89. GlaxoSmithKline (GSK) Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. GlaxoSmithKline (GSK) Phenylpropanolamine Product Offerings
    Table 91. GlaxoSmithKline (GSK) Recent Development
    Table 92. Roemmers Company Information
    Table 93. Roemmers Introduction and Business Overview
    Table 94. Roemmers Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Roemmers Phenylpropanolamine Product Offerings
    Table 96. Roemmers Recent Development
    Table 97. Armoxindo Company Information
    Table 98. Armoxindo Introduction and Business Overview
    Table 99. Armoxindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Armoxindo Phenylpropanolamine Product Offerings
    Table 101. Armoxindo Recent Development
    Table 102. Asuncion Company Information
    Table 103. Asuncion Introduction and Business Overview
    Table 104. Asuncion Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Asuncion Phenylpropanolamine Product Offerings
    Table 106. Asuncion Recent Development
    Table 107. Medlink Company Information
    Table 108. Medlink Introduction and Business Overview
    Table 109. Medlink Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Medlink Phenylpropanolamine Product Offerings
    Table 111. Medlink Recent Development
    Table 112. Sanofi-Aventis Company Information
    Table 113. Sanofi-Aventis Introduction and Business Overview
    Table 114. Sanofi-Aventis Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Sanofi-Aventis Phenylpropanolamine Product Offerings
    Table 116. Sanofi-Aventis Recent Development
    Table 117. Tempo Scan Pacific Company Information
    Table 118. Tempo Scan Pacific Introduction and Business Overview
    Table 119. Tempo Scan Pacific Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Tempo Scan Pacific Phenylpropanolamine Product Offerings
    Table 121. Tempo Scan Pacific Recent Development
    Table 122. Carinopharm Company Information
    Table 123. Carinopharm Introduction and Business Overview
    Table 124. Carinopharm Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Carinopharm Phenylpropanolamine Product Offerings
    Table 126. Carinopharm Recent Development
    Table 127. Meda Company Information
    Table 128. Meda Introduction and Business Overview
    Table 129. Meda Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Meda Phenylpropanolamine Product Offerings
    Table 131. Meda Recent Development
    Table 132. IBL Healthcare Company Information
    Table 133. IBL Healthcare Introduction and Business Overview
    Table 134. IBL Healthcare Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. IBL Healthcare Phenylpropanolamine Product Offerings
    Table 136. IBL Healthcare Recent Development
    Table 137. Gracia Pharmindo Company Information
    Table 138. Gracia Pharmindo Introduction and Business Overview
    Table 139. Gracia Pharmindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Gracia Pharmindo Phenylpropanolamine Product Offerings
    Table 141. Gracia Pharmindo Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Phenylpropanolamine Downstream Customers
    Table 145. Phenylpropanolamine Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Phenylpropanolamine Product Picture
    Figure 2. Global Phenylpropanolamine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Phenylpropanolamine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Phenylpropanolamine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Phenylpropanolamine Report Years Considered
    Figure 7. Global Phenylpropanolamine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Phenylpropanolamine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Phenylpropanolamine Revenue in 2023
    Figure 10. Phenylpropanolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tablet Picture
    Figure 12. Capsule Picture
    Figure 13. Syrup Picture
    Figure 14. Global Phenylpropanolamine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Phenylpropanolamine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Phenylpropanolamine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Phenylpropanolamine Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Phenylpropanolamine Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Human
    Figure 20. Product Picture of Veterinary
    Figure 21. Global Phenylpropanolamine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Phenylpropanolamine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Phenylpropanolamine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Phenylpropanolamine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Phenylpropanolamine Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Phenylpropanolamine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Phenylpropanolamine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Phenylpropanolamine Sales Volume (%), (2019-2030)
    Figure 38. United States Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Phenylpropanolamine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Phenylpropanolamine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Phenylpropanolamine Industrial Chain
    Figure 60. Phenylpropanolamine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS